Skip Navigation
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients
Search
Home » Advanced Search
Search Results for quinidine
Perform Another (Advanced) Search
Related Words: quinidine
12 Results within Entire Site
Limit results to show: Entire Site Clinical Trial Listings Newly Approved Drugs Research Center Profiles Industry Providers New Medical Results Clinical Trials Today Headlines
1. CenterWatch: New Medical Therapies in Disease Category (608), Pseudobulbar Affect ...August 17, 2009 Avanir released positive results from a phase III trial of Zenvia (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). This double-blind, randomized, placebo-controlled, international study ......Pharmaceuticals reported positive results of its first phase III trial of their drug Neurodex (dextromethorphan/quinidine) , for the treatment of pseudobulbar affect in patients with amyotrophic lateral sclerosis. Trial data indicated ...View Page
2. Study Posting (77) Trial #138520, Neurologic Disorders, New York, NY ...and schizophrenia) • Have active epilepsy • Have liver or kidney failure • Have been treated with quinine, quinidine, chloroquine, or halofantrine • Are pregnant, breastfeeding, or intend to become pregnant during the study • Have ...View Page
3. CenterWatch: New Medical Therapies in Disease Category (253), Diabetic Neuropathy ...23, 2007 Avanir announced positive results from a phase III trial of Zenvia (dextromethorphan hydrobromide/quinidine sulfate, "DMQ") for the treatment of diabetic neuropathic pain. This randomized, double-blind, placebo-controlled ......Israel. Subjects were placed into one of three treatment arms: 45 mg dextromethorphan /30 mg quinidine (DMQ 45) BID dose, 30 mg dextromethorphan / 30 mg quinidine BID dose (DMQ 30) and ...View Page
4. Study Posting (1918) Trial #160135, Metastatic Cancer, Savannah, GA ...Select anesthetics (e.g., ketamine, propofol) • Hypericum perforatum (St. John's wort) • Nefazodone • Nicardipine • Diclofenac • Quinidine • Imatinib mesylate • At least 7 days since prior and no concurrent medications that prolong the QTc interval, including any of the following: • Antiarrhythmic agents (e.g., quinidine, procainamide, disopyramide phosphate, amiodarone, sotalol hydrochloride, ibutilide, dofetilide) • Antipsychotic agents (e.g., chlorpromazine, mesoridazine, thioridazine ...View Page
5. Study Posting (1918) Trial #160134, Breast Cancer, Savannah, GA ...Select anesthetics (e.g., ketamine, propofol) • Hypericum perforatum (St. John's wort) • Nefazodone • Nicardipine • Diclofenac • Quinidine • Imatinib mesylate • At least 7 days since prior and no concurrent medications that prolong the QTc interval, including any of the following: • Antiarrhythmic agents (e.g., quinidine, procainamide, disopyramide phosphate, amiodarone, sotalol hydrochloride, ibutilide, dofetilide) • Antipsychotic agents (e.g., chlorpromazine, mesoridazine, thioridazine ...View Page
6. CenterWatch: New Medical Therapies in Disease Category (215), Neuropathy ...Pharmaceuticals reported positive results of its first phase III trial of their drug Neurodex (dextromethorphan/quinidine) , for the treatment of pseudobulbar affect in patients with amyotrophic lateral sclerosis. Trial data indicated ......drugs (3.3 points greater vs. dextromethorphan, p=0.001; 3.7 points greater vs. quinidine, p<0.001). The drug also met all secondary endpoints, including reduction in affect episode ...View Page
7. CenterWatch: New Medical Therapies in Disease Category (160), Amyotrophic Lateral Sclerosis (ALS) ...Pharmaceuticals reported positive results of its first phase III trial of their drug Neurodex (dextromethorphan/quinidine) , for the treatment of pseudobulbar affect in patients with amyotrophic lateral sclerosis. Trial data indicated ......drugs (3.3 points greater vs. dextromethorphan, p=0.001; 3.7 points greater vs. quinidine, p<0.001). The drug also met all secondary endpoints, including reduction in affect episode ...View Page
8. CenterWatch: New Medical Therapies in Disease Category (107), Obesity ...23, 2007 Avanir announced positive results from a phase III trial of Zenvia (dextromethorphan hydrobromide/quinidine sulfate, "DMQ") for the treatment of diabetic neuropathic pain. This randomized, double-blind, placebo-controlled ......Israel. Subjects were placed into one of three treatment arms: 45 mg dextromethorphan /30 mg quinidine (DMQ 45) BID dose, 30 mg dextromethorphan / 30 mg quinidine BID dose (DMQ 30) and ...View Page
9. Study Posting (1918) Trial #158907, Lung Cancer, Savannah, GA ...s wort) • Efavirenz • Tipranavir • No concurrent agents with proarrhythmic potential, including any of the following: • Quinidine • Procainamide • Disopyramide • Sotalol • Probucol • Haloperidol • Risperidone • Indapamide • Flecainide • No concurrent therapeutic anticoagulation for thromboembolic disease ...View Page
10. Study Posting (1918) Trial #159917, Kidney Cancer, Savannah, GA ...or phenobarbital) • Hypericum perforatum (St. John's wort) • Ketoconazole • Dexamethasone • Dysrhythmic drugs (i.e., terfenadine, quinidine, procainamide, sotalol, probucol, bepridil, indapamide, or flecainide) • Haloperidol • Risperidone • Rifampin • Grapefruit juice or grapefruit NOTE ...View Page
11. Study Posting (1918) Trial #158881, Brain Tumor, Savannah, GA ...cancer allowed • Concurrent hormonal therapy for breast or prostate cancer allowed • No concurrent bethanechol, ketoconazole, quinidine, or succinylcholine • No prior GliaSite or other type of brain brachytherapy, convection enhanced delivery of ...View Page
12. Newly Approved Drug Therapies (64) Crixivan (Indinavir sulfate), Merck, ...and zidovudine, d4T, lamivudine, fluconazole, clarithromycin, trimethoprim/sulfamethoxazole, isoniazid, Ortho-Novum 1/35, cimetidine, and quinidine. Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 Jobson Medical Information LLC. Designed by Piehead ...View Page
Copyright © 2008 Jobson Medical Information LLC.
Designed by Piehead Productions LLC.